Circulatory Archives - Page 12 of 24

News
Subsegmental PEs overtreated despite link with patient harm
May 28, 2019
How often are physicians treating isolated subsegmental pulmonary embolisms?
News
Posthospitalization thromboprophylaxis with rivaroxaban is unnecessary
May 21, 2019
Do symptomatic venous thromboembolism (VTE) complications improve with posthospitalization thromboprophylaxis using rivaroxaban for an at-risk medical population?
News
Rivaroxaban versus heparin at preventing recurrent, cancer-related VTE
April 12, 2019
Is an oral direct factor Xa inhibitor an effective alternative to low-molecular-weight heparin (LMWH) in treating cancer related venous thromboembolism (VTE)?
News
IVC filter placement increases mortality in some VTE patients
April 9, 2019
How does inferior vena cava (IVC) filter placement affect 30-day mortality in patients with venous thromboembolism (VTE) with increased risk of bleeding when anticoagulation is not feasible?
News
Ticagrelor reversal agent looks promising
March 28, 2019
NEW ORLEANS – Ticagrelor’s antiplatelet effect was squelched within 5 minutes.
News
Occurrence of pulmonary embolisms in hospitalized patients nearly doubled during 2004-2015
March 24, 2019
NEW ORLEANS – National Inpatient Sample data showed that during 2004-2015 hospitalized U.S. patients with a PE diagnosis jumped by 80%.
News
Andexanet alfa effectively reverses factor Xa inhibition
March 18, 2019
HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated with factor Xa inhibition.
News
Supplementary compression doesn’t improve DVT odds in critically ill
February 20, 2019
SAN DIEGO – The procedure carries few risks, aside from patient discomfort.
News
PERT alerts improve pulmonary embolism outcomes
February 20, 2019
SAN DIEGO – Alerts that prompt multidisciplinary consultations cut death rates, ICU times in pulmonary embolism patients.
News
When is it safe to resume anticoagulation in my patient with hemorrhagic stroke?
February 5, 2019
Robust scientific data on when to resume anticoagulation after ICH does not exist.